Kim M - Search Results

1

De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathy.

Long PA, Zimmermann MT, Kim M, Evans JM, Xu X, Olson TM. Long PA, et al. Among authors: kim m. Hum Genet. 2016 Aug;135(8):909-917. doi: 10.1007/s00439-016-1685-3. Epub 2016 May 27. Hum Genet. 2016. PMID: 27234373 Free PMC article.

2

Exon- and contraction-dependent functions of titin in sarcomere assembly.

Shih YH, Dvornikov AV, Zhu P, Ma X, Kim M, Ding Y, Xu X. Shih YH, et al. Among authors: kim m. Development. 2016 Dec 15;143(24):4713-4722. doi: 10.1242/dev.139246. Epub 2016 Nov 11. Development. 2016. PMID: 27836965 Free PMC article.

3

Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity.

Ma X, Zhu P, Ding Y, Zhang H, Qiu Q, Dvornikov AV, Wang Z, Kim M, Wang Y, Lowerison M, Yu Y, Norton N, Herrmann J, Ekker SC, Hsiai TK, Lin X, Xu X. Ma X, et al. Among authors: kim m. Sci Adv. 2020 Jan 29;6(5):eaay2939. doi: 10.1126/sciadv.aay2939. eCollection 2020 Jan. Sci Adv. 2020. PMID: 32064346 Free PMC article.

4

TFEB Overexpression, Not mTOR Inhibition, Ameliorates RagC^S75Y Cardiomyopathy.

Kim M, Lu L, Dvornikov AV, Ma X, Ding Y, Zhu P, Olson TM, Lin X, Xu X. Kim M, et al. Int J Mol Sci. 2021 May 23;22(11):5494. doi: 10.3390/ijms22115494. Int J Mol Sci. 2021. PMID: 34071043 Free PMC article.

5

Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies.

Stutzman MJ, Gao X, Kim M, Ye D, Zhou W, Tester DJ, Giudicessi JR, Shannon K, Ackerman MJ. Stutzman MJ, et al. Among authors: kim m. Heart Rhythm. 2023 May;20(5):709-717. doi: 10.1016/j.hrthm.2023.01.032. Epub 2023 Jan 31. Heart Rhythm. 2023. PMID: 36731785

6

Development of a Patient-Specific p.D85N-Potassium Voltage-Gated Channel Subfamily E Member 1-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for Drug-Induced Long QT Syndrome.

Kim M, Ye D, John Kim CS, Zhou W, Tester DJ, Giudicessi JR, Ackerman MJ. Kim M, et al. Circ Genom Precis Med. 2021 Jun;14(3):e003234. doi: 10.1161/CIRCGEN.120.003234. Epub 2021 May 18. Circ Genom Precis Med. 2021. PMID: 34003017

7

SGK1 inhibition attenuated the action potential duration in patient- and genotype-specific re-engineered heart cells with congenital long QT syndrome.

Kim M, Das S, Tester DJ, Pradhananga S, Hamrick SK, Gao X, Srinivasan D, Sager PT, Ackerman MJ. Kim M, et al. Heart Rhythm O2. 2023 Feb 16;4(4):268-274. doi: 10.1016/j.hroo.2023.02.003. eCollection 2023 Apr. Heart Rhythm O2. 2023. PMID: 37124559 Free PMC article.

8

SGK1 inhibition attenuates the action potential duration in reengineered heart cell models of drug-induced QT prolongation.

Kim M, Sager PT, Tester DJ, Pradhananga S, Hamrick SK, Srinivasan D, Das S, Ackerman MJ. Kim M, et al. Heart Rhythm. 2023 Apr;20(4):589-595. doi: 10.1016/j.hrthm.2022.12.036. Epub 2023 Jan 5. Heart Rhythm. 2023. PMID: 36610526

9

Supercycle Al-Doped ZnMgO Alloys via Atomic Layer Deposition for Quantum Dot Light-Emitting Diodes.

Lee HG, Kwon YW, Jung WH, Lee H, Kim MS, Kim HM, Kim H, Kim HJ, Lee DC, Lim J, Cho SY. Lee HG, et al. Among authors: kim ms. ACS Appl Mater Interfaces. 2025 Jan 6. doi: 10.1021/acsami.4c17722. Online ahead of print. ACS Appl Mater Interfaces. 2025. PMID: 39760670

10

A relationship analysis of the effects of COVID-19 isolation on pressure sores in a tertiary hospital.

Kim MJ, Lee JS, Mok JH, Lim H, Hahn HM, Lee IJ. Kim MJ, et al. Int Wound J. 2024 Feb;21(2):e14679. doi: 10.1111/iwj.14679. Int Wound J. 2024. PMID: 39760533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50,770 results

Search Page

Filters